Takeda takes full control of drug for rare epilepsies

Retrieved on: 2021-03-03 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Takeda takes full control of drug for rare epilepsies. View article details on hiswai:

Excerpt

BioPharma Dive Jazz Pharma to buy GW Pharma, maker of CBD-based epilepsy drug, for $7.2B offsite link. Follow Jacob Bell on Twitter.

Article found on: www.biopharmadive.com